Shanghai King-cell Biotechnology Co., Ltd. was established in Shanghai Jinshan Industrial Zone in April 19, 2017, is a commitment to innovation and safe vaccine R & D and production of bio pharmaceutical enterprises. The company formerly known as Zhongguancun is located in Beijing Beijing Purcell Forest Biotechnology Co. Ltd., after careful research for more than 6 years, in the domestic first Purified Hamster Kidney Cell Rabies Vaccine (CEF cell) clinical document will be completed; the new genotype with MMR vaccine development of inactivated rotavirus vaccine and respiratory syncytial virus vaccine.
The company in the Jinshan Industrial Zone covers an area of 80 acres, the first phase of construction including Purified Hamster Kidney Cell Rabies Vaccine (CEF), Purified Hamster Kidney Cell Rabies Vaccine (human diploid cell) workshop, quality inspection building, animal laboratory, pilot plant and warehouse complex totaling 91 thousand square meters,
The company does not seek the expansion of the scale of production, only the pursuit of product safety and effectiveness, in the spirit of craftsman manufacturing services for human health products, and strive to become honest, dignified, influential enterprises
We firmly believe that vaccines are made for human beings and not for profit seeking. As long as we adhere to this belief, profits will follow. We will develop innovative and safe vaccines to improve human health and benefit mankind
Honest, kind and ingenuity to create, for the benefit of mankind
Contact：Shanghai King-cell Biotechnology Co., Ltd.
Address： Shanghai Jin Shan